Marco Puthenparampil

10PUBLICATIONS
26CO-AUTHORS
Medical infection agents (incl. prions)Medical biotechnology diagnostics (incl. biosensors)OptometryInnate immunityInfant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Nov 14, 2025
The clinical relevance of hyper-reflective foci in the inner retina at the diagnosis of multiple sclerosis.

Marco Puthenparampil, Alessandro Miscioscia, Elisa Basili

|Oct 02, 2025
Optic nerve as a 5th location in the revised McDonald diagnostic criteria for multiple sclerosis: limitations of OCT in the acute phase.

Valentina Annamaria Mauceri, Marco Puthenparampil, Paolo Gallo

|Aug 28, 2025
Intrathecal Anti-Akkermansia muciniphila IgG Responses in Multiple Sclerosis Patients Linked to CSF Immune Cells and Disease Activity.

Carolina Cruciani, Camille Mathé, Marco Puthenparampil

|Aug 14, 2024
High NEDA and No PIRA in Natalizumab-Treated Patients With Pediatric-Onset Multiple Sclerosis.

Marco Puthenparampil, Marta Gaggiola, Marta Ponzano

|Oct 09, 2023
Alemtuzumab following natalizumab is more effective in adult-onset than paediatric-onset multiple sclerosis.

Marco Puthenparampil, Marta Gaggiola, Alessandro Miscioscia

Pageof 2